Insider Buying: Option Care Health, Inc. (NASDAQ:OPCH) Director Purchases 43,000 Shares of Stock

Option Care Health, Inc. (NASDAQ:OPCH) Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $21.93 on Friday. The business has a fifty day moving average of $28.82 and a 200-day moving average of $29.44. The firm has a market cap of $3.73 billion, a PE ratio of 18.43, a price-to-earnings-growth ratio of 2.30 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a twelve month low of $21.64 and a twelve month high of $34.63.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Barrington Research dropped their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Harbor Capital Advisors Inc. increased its stake in shares of Option Care Health by 317.9% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after buying an additional 73,312 shares during the period. Comerica Bank boosted its holdings in Option Care Health by 6.5% in the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after acquiring an additional 46,639 shares during the last quarter. Janus Henderson Group PLC increased its position in Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after purchasing an additional 146,837 shares during the period. Edgestream Partners L.P. raised its holdings in Option Care Health by 96.8% during the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its position in Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after purchasing an additional 1,585,818 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.